AZ-W-L-GORE-&-ASSOC
27.4.2016 09:07:39 CEST | Business Wire | Press release
W. L. Gore & Associates (Gore) joined with leaders across the vascular and endovascular community in honoring four European physicians as Pioneers in Performance . The biennial award acknowledges exceptional work in the field of vascular and endovascular therapy, including aortic and lower-limb bypass and dialysis access surgery.
Selected by past award recipients in four categories that corresponded with different aspects of clinical collaboration, each winner was selected through popular vote. By submitting for the nominee of their choice on PioneersinPerformance.com , the broader medical community chose to recognize the following 2016 honorees on the evening of Tuesday, April 26 at the Gore MEDICAL MASTERY Learning Center at the Charing Cross International Symposium in London.
Commitment to Ongoing Learning :
- Amman Bolia, MD, Consultant Radiologist, University Hospitals of Leicester NHS Trust, Leicester, UK
Dedication to Sharing Knowledge with Peers and Patients :
- Jean-Baptiste Ricco MD, PhD, Professor of Vascular Surgery, University Hospital of Poitiers, Poitiers, France
Dedication to Creating Consensus within the Medical Community :
- Hans van Overhagen, MD, PhD, EBIR, Department of Radiology, Haga Teaching Hospital, The Hague, The Netherlands
Dedication to Analysis of Clinical Outcomes:
- Martin Malina, MD, PhD, Vascular and Endovascular Surgeon Consultant, Malmo University Hospital, Malmo, Sweden
Dr. Ross Naylor, a past recipient of the award, noted, “The Pioneers in Performance award program offers a unique opportunity for the vascular community to recognize its own. The exemplarily individuals receiving this year’s award encompass the true spirit of innovation. Congratulations to all of this year’s honorees.”
“The Pioneers in Performance program brings together physicians from all corners of the globe to recognize their fellow physicians for their unwavering dedication to advancing vascular and endovascular therapy and minimally invasive treatment options for patients worldwide,” said Ryan Takeuchi, Gore Aortic Business Leader. “We congratulate and thank this year’s honorees and nominees for their part in driving the industry forward and enhancing the patient experience.”
About W. L. Gore & Associates
At Gore Medical, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit GoreMedical@Chempetitive.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160427005357/en/
Contact:
Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo,
(312) 997-2436
GoreMedical@Chempetitive.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New ABB and BCG Report Highlights Growing Role of Direct Current Technologies in Future Power Systems9.9.2026 11:42:00 CEST | Press release
Rapid expansion of AI computing, increasing electrification and rise of renewable energy are driving renewed interest in DC technology as part of future electrical systems Both AC and DC systems have strategically important roles in meeting future electricity demand Establishing common standards and developing DC-specific skills can help accelerate deployment ABB today published a new report, The Strategic Case for Hybrid AC/DC Power: Shaping the Transition to the Next Electrical Architecture, developed in collaboration with Boston Consulting Group (BCG). The report makes the case that direct current (DC) technology is moving from the periphery to the center of industrial, commercial, and digital infrastructure – and that the decisions made by business leaders and policymakers in the next two to three years will determine who shapes that transition and who inherits it. The future of power distribution is not an either-or choice between alternating current (AC) and direct current, but a
Visa and World Bank Group Announce New Risk-Sharing Initiative to Expand Digital Payments and Financial Inclusion in Emerging Markets9.9.2026 11:00:00 CEST | Press release
Visa (NYSE: V), a global leader in digital payments, and the International Finance Corporation (IFC), a member of the World Bank Group focused on the private sector, are partnering on an innovative risk-sharing initiative designed to help expand financial inclusion by increasing access to digital financial services in emerging markets. Under the agreement, IFC will share credit settlement risk for Visa transactions associated with enrolled financial institutions, enabling these institutions to connect more underbanked consumers and small businesses to digital payments. The facility is expected to support approximately $200 million in risk sharing over five years, with an initial focus on 14 countries in Latin America and the Caribbean and reach approximately 50 financial institutions with below-investment grade ratings. Together, Visa and IFC aim to help financial institutions enable millions more people and small businesses to save, spend, borrow, grow, and participate more fully in t
Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities9.9.2026 11:00:00 CEST | Press release
HIGHLIGHTS H1 2026 revenues of €1.89 billion, up +3.6% at CER versus H1 2025, driven by growth in the inhaled triple therapy portfolio and strong momentum in the rare diseases therapeutic area Continued investment in innovation with €426 million invested in R&D (22.5% of sales) Completed strategic investment for treatment of hereditary angioedema (HAE) with acquisition of KalVista Pharmaceuticals EBITDA continues to remain close to 30%, reflecting continued strong profitability and disciplined resource allocation Recent Economic Footprint study highlights Chiesi's contribution to economic development, supporting 56,488 jobs globally, generating €6.0 billion in GDP impact and €2.0 billion in taxes and public revenues worldwide Chiesi Group ("Chiesi"), an international research-focused biopharmaceutical company and certified B Corp, today announced its financial results for the six months ended 30 June 2026 ("H1 2026"). Performance across therapeutic areas and regions Chiesi reported rev
Ant Group Open-Sources Ling-3.0-flash-Fin for Real-World Financial Workflows9.9.2026 10:36:00 CEST | Press release
Ant Group today announced the open-sourcing of Ling-3.0-flash-Fin at the 2026 Inclusion·Conference on the Bund. Grounded in actual business needs as an open model for real-world financial workflows, this release continues Ant Group's exploration of bringing AI into practical scenarios, focusing on delivering utility and high efficiency for complex tasks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908565055/en/ Solving Real-World Challenges Through Efficiency Financial work depends on trustworthy sources, consistent definitions, accurate calculations and auditable outputs. AI in this sector must go beyond simple question-and-answer interactions to navigate dynamic information, complex accounting standards, and stringent compliance requirements. Ling-3.0-flash-Fin was co-developed with leading financial institutions and industry experts to embed professional expertise directly into task definition, data systems, and eva
1NCE adds Data Benchmarking, AI Capabilities and ISO certification9.9.2026 10:00:00 CEST | Press release
1NCE Insights now offers access to benchmarks from 30,000+ global deployments across 17 industries, enabling customers to compare their solutions to real-world peers. Launch of 1NCE AI, a unified API gateway providing access to leading AI models with centralized vendor management. ISO/IEC 27001:2022 certified infrastructure, reflecting 1NCE's commitment to data security. 1NCE announced a new upgrade of 1NCE Insights and the launch of 1NCE AI. Both expand 1NCE's foundational platform services, giving customers greater intelligence and control over connected device data. The new 1NCE Insights upgrade gives customers access to aggregated benchmark data from 30,000+ deployments. They can compare network usage patterns, battery performance, hardware choices and traffic optimization against real-world peers, enabling faster product development. 1NCE AI provides access to leading AI models through a unified API gateway, eliminating vendor fragmentation. The service is Germany-hosted and fully
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
